Tyrosine supplementation as an adjunct treatment in anorexia nervosa - a noradrenergic repletion hypothesis

Hart, M; Wilcken, B; Williams, L; Sibbritt, D; Nunn, KP

Tyrosine supplementation as an adjunct treatment in anorexia nervosa - a noradrenergic repletion hypothesis

Hart, M Wilcken, B Williams, L Sibbritt, D

Nunn, KP

Permalink

Publisher:: Taylor & Francis (Routledge): STM, Behavioural Science and Public Health Titles
Publication Type:: Journal Article
Citation:: Advances in Eating Disorders: Theory, Research and Practice, 2013, 1 (2), pp. 161 - 168
Issue Date:: 2013-03-21

Closed Access

	Filename	Description	Size
	2012006628OK.pdf		218.6 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Hart, M	en_US
dc.contributor.author	Wilcken, B	en_US
dc.contributor.author	Williams, L	en_US
dc.contributor.author	Sibbritt, D https://orcid.org/0000-0003-3561-9447	en_US
dc.contributor.author	Nunn, KP	en_US
dc.date.issued	2013-03-21	en_US
dc.identifier.citation	Advances in Eating Disorders: Theory, Research and Practice, 2013, 1 (2), pp. 161 - 168	en_US
dc.identifier.issn	2166-2630	en_US
dc.identifier.uri	http://hdl.handle.net/10453/26746
dc.description.abstract	Anorexia nervosa (AN) is accompanied by an increased frequency of pre-morbid anxiety. Anxiety disorders are associated with increased brain activity of catecholamines, especially noradrenaline. It has been hypothesized that noradrenergic dysregulation may be a major factor in the causation of AN.	en_US
dc.publisher	Taylor & Francis (Routledge): STM, Behavioural Science and Public Health Titles	en_US
dc.relation.ispartof	Advances in Eating Disorders: Theory, Research and Practice	en_US
dc.relation.isbasedon	10.1080/21662630.2013.742978	en_US
dc.title	Tyrosine supplementation as an adjunct treatment in anorexia nervosa - a noradrenergic repletion hypothesis	en_US
dc.type	Journal Article
utslib.citation.volume	2	en_US
utslib.citation.volume	1	en_US
utslib.for	1116 Medical Physiology	en_US
utslib.for	1117 Public Health and Health Services	en_US
utslib.for	1701 Psychology	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/Public Health
pubs.organisational-group	/University of Technology Sydney/Strength - CHSP - Health Services and Practice
utslib.copyright.status	closed_access
pubs.consider-herdc	false	en_US
pubs.issue	2	en_US
pubs.volume	1	en_US

Abstract:

Anorexia nervosa (AN) is accompanied by an increased frequency of pre-morbid anxiety. Anxiety disorders are associated with increased brain activity of catecholamines, especially noradrenaline. It has been hypothesized that noradrenergic dysregulation may be a major factor in the causation of AN.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/26746